The Latin America, Middle East and Africa Inhalation Anesthesia Market would witness market growth of 10.7% CAGR during the forecast period (2022-2028).
In the operating room, inhalation anesthetics (nitrous oxide, isoflurane, halothane, sevoflurane, and desflurane are the most often used agents today) are used to induce and maintain general anesthesia. The volatile anesthetics (halothane, isoflurane, desflurane, and sevoflurane) are liquids at room temperature and must be administered using vaporizers. Under normal temperature and pressure, nitrous oxide is already present. Except for nitrous oxide, which also delivers analgesia, all inhalational anesthetics cause amnesia and immobility. Inhaled anesthetics are frequently used in conjunction with intravenous anesthetics. These drugs have been approved by the FDA for use in the operating room as general anesthetic and sedative agents.
The United Arab Emirates spends 4.28 percent of its budget on healthcare. The UAE government has made building a world-class healthcare infrastructure a primary priority, and as a result, the industry has grown and expanded tremendously in recent years. According to the World Health Organization, one-third of adults in the UAE are obese, and one out of every five persons has diabetes. As the prevalence of lifestyle diseases rises, these people will require higher-quality healthcare, owing to their relatively high-income levels. The government is concentrating its efforts on building a healthcare infrastructure to meet this demand.
Both the federal and emirate levels of government oversee healthcare in the UAE. Federal legislation stems from the 1970s and 1980s, and there are currently pending legislative reform proposals to help the healthcare business develop. The UAE government is liberalizing rules in order to attract international investment and raise the standard of healthcare in the country.
The Brazil market dominated the LAMEA Inhalation Anesthesia Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $33.7 Million by 2028. The Argentina market is poised to grow at a CAGR of 11.3% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 10.4% during (2022 - 2028).
Based on Drug, the market is segmented into Sevoflurane, Desflurane, Isoflurane, and Others. Based on Application, the market is segmented into Maintenance and Induction. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Inhalation Anesthesia Market is Predict to reach $1.9 Billion by 2028, at a CAGR of 8.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novartis AG, Piramal Enterprises Limited, Hikma Pharmaceuticals PLC, Fresenius SE & Co. KGaA, Baxter International, Inc., AbbVie, Inc., Halocarbon Products Corporation, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., and Troikaa Pharmaceuticals Limited.
Scope of the Study
Market Segments Covered in the Report:
By Drug
- Sevoflurane
- Desflurane
- Isoflurane
- Others
By Application
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Novartis AG
- Piramal Enterprises Limited
- Hikma Pharmaceuticals PLC
- Fresenius SE & Co. KGaA
- Baxter International, Inc.
- AbbVie, Inc.
- Halocarbon Products Corporation
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Lunan Pharmaceutical Group Co., Ltd.
- Troikaa Pharmaceuticals Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Inhalation Anesthesia Market, by Drug
1.4.2 LAMEA Inhalation Anesthesia Market, by Application
1.4.3 LAMEA Inhalation Anesthesia Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Inhalation Anesthesia Market by Drug
3.1 LAMEA Sevoflurane Market by Country
3.2 LAMEA Desflurane Market by Country
3.3 LAMEA Isoflurane Market by Country
3.4 LAMEA Others Market by Country
Chapter 4. LAMEA Inhalation Anesthesia Market by Application
4.1 LAMEA Maintenance Market by Country
4.2 LAMEA Induction Market by Country
Chapter 5. LAMEA Inhalation Anesthesia Market by Country
5.1 Brazil Inhalation Anesthesia Market
5.1.1 Brazil Inhalation Anesthesia Market by Drug
5.1.2 Brazil Inhalation Anesthesia Market by Application
5.2 Argentina Inhalation Anesthesia Market
5.2.1 Argentina Inhalation Anesthesia Market by Drug
5.2.2 Argentina Inhalation Anesthesia Market by Application
5.3 UAE Inhalation Anesthesia Market
5.3.1 UAE Inhalation Anesthesia Market by Drug
5.3.2 UAE Inhalation Anesthesia Market by Application
5.4 Saudi Arabia Inhalation Anesthesia Market
5.4.1 Saudi Arabia Inhalation Anesthesia Market by Drug
5.4.2 Saudi Arabia Inhalation Anesthesia Market by Application
5.5 South Africa Inhalation Anesthesia Market
5.5.1 South Africa Inhalation Anesthesia Market by Drug
5.5.2 South Africa Inhalation Anesthesia Market by Application
5.6 Nigeria Inhalation Anesthesia Market
5.6.1 Nigeria Inhalation Anesthesia Market by Drug
5.6.2 Nigeria Inhalation Anesthesia Market by Application
5.7 Rest of LAMEA Inhalation Anesthesia Market
5.7.1 Rest of LAMEA Inhalation Anesthesia Market by Drug
5.7.2 Rest of LAMEA Inhalation Anesthesia Market by Application
Chapter 6. Company Profiles
6.1 Novartis AG
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches and Product Expansions:
6.2 Piramal Enterprises Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Hikma Pharmaceuticals PLC
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.4 Fresenius SE & Co. KGaA
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.5 Baxter International, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Approvals and Trials:
6.6 AbbVie, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 Halocarbon Products Corporation
6.7.1 Company Overview
6.8 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
6.8.1 Company Overview
6.9 Lunan Pharmaceutical Group Co., Ltd.
6.9.1 Company Overview
6.10. Troikaa Pharmaceuticals Limited
6.10.1 Company Overview
TABLE 1 LAMEA Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 4 LAMEA Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 5 LAMEA Sevoflurane Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Sevoflurane Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Desflurane Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Desflurane Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Isoflurane Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Isoflurane Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 14 LAMEA Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 15 LAMEA Maintenance Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Maintenance Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Induction Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Induction Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Inhalation Anesthesia Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Inhalation Anesthesia Market by Country, 2022 - 2028, USD Million
TABLE 21 Brazil Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 22 Brazil Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 23 Brazil Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 24 Brazil Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 25 Brazil Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 26 Brazil Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 27 Argentina Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 28 Argentina Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 29 Argentina Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 30 Argentina Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 31 Argentina Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 32 Argentina Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 33 UAE Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 34 UAE Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 35 UAE Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 36 UAE Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 37 UAE Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 38 UAE Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 39 Saudi Arabia Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 40 Saudi Arabia Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 41 Saudi Arabia Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 42 Saudi Arabia Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 43 Saudi Arabia Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 44 Saudi Arabia Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 45 South Africa Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 46 South Africa Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 47 South Africa Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 48 South Africa Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 49 South Africa Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 50 South Africa Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 51 Nigeria Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 52 Nigeria Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 53 Nigeria Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 54 Nigeria Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 55 Nigeria Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 56 Nigeria Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 57 Rest of LAMEA Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 58 Rest of LAMEA Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 59 Rest of LAMEA Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 60 Rest of LAMEA Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 61 Rest of LAMEA Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 62 Rest of LAMEA Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 63 Key Information – Novartis AG
TABLE 64 Key Information – Piramal Enterprises Limited
TABLE 65 Key Information – Hikma Pharmaceuticals PLC
TABLE 66 key information – Fresenius SE & Co. KGaA
TABLE 67 Key Information – Baxter International, Inc.
TABLE 68 Key information – AbbVie, Inc.
TABLE 69 Key Information – Halocarbon Products Corporation
TABLE 70 Key Information – Jiangsu Hengrui Pharmaceuticals Co., Ltd.
TABLE 71 Key Information – Lunan Pharmaceutical Group Co., Ltd.
TABLE 72 key Information – Troikaa Pharmaceuticals Limited
List of Figures
FIG 1 Methodology for the research